Cowan Elvia, SVP, reported a transaction classified as withholding at Vaxcyte, Inc. involving 325.000000 shares for an estimated $23432.50. Reported holdings after the transaction were 24106.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
SVP, FINANCE
Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The
RSUs vest as to 25% of the shares subject to the award on September 7, 2025 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer
through each such date.
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
1/48 of shares subject to the option vest on March 27, 2025, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.
0 other filings
0 recent txs